Clinical Trial Update: A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two approved drugs for osteoarthritis has completed; trial results are not detailed in the provided summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED